A series of triorganophosphinegold(1) dithiocarbamate (R3PAuS2CNR'2) and xanthate (R3PAuS:COR') complexes have been prepared and characterised spectroscopically. Based on crystallographic evidence, the molecules feature linear gold(1) geometries defined by sulphur and phosphorus donors. The complexes, along with a series of known anti-cancer agents, have been screened against a panel of seven human cancer cell lines. Uniformly, the dithiocarbamate derivatives are more active than their xanthate counterparts, with the most active complex being Et3PAu(S:CNEt2), and are more active than cisplatin in all cell lines screened but, not as potent as taxol.
INTRODUCTION
Amongst the l,l-dithiolate ligands, dithiocarbamates, SzCNR2, comprise a group of ligands with great binding potential to metals and as such find wide use in coordination chemistry. Their synthesis is relatively simple with the most common method of preparation involving the reaction of carbon disulphide, in the presence of a base such as sodium or potassium hydroxide, with any one of a large range of primary and secondary amines/1, 2/. Dithiocarbamates and their metal complexes have a wide variety of applications.
Their most common use is as pesticides, e.g. zineb, [Zn(SzCN(H) CH2CHzN(H)CS:)],, maneb, [Mn(SCN(H)CH2CH2N(H)CSz)]n, ziram, Zn(SzCNMe2)2, and thiram, Me2NC(=S)SSC(=S)NMe:, and this application has led to the development of new analytical techniques that were designed to determine the concentrations of these pesticides as well as their degradation products/2 4/. In addition, these species have important applications in the production of petroleum derivatives, lubricants and polymers, where they are Among the various different classes of metal complexes currently investigated for their applications in medicine, dithiocarbamate complexes demonstrate outstanding potential/23/. The potential medical uses of dithiocarbamate complexes include: anti-viral agents, e.g. heterocyclic dithiocarbamates of ruthenium(Ill) /24/, antidotes for preventing the effects of phytotoxic agents, e.g. copper dithiocarbamates/25/, bactericides and anti-microbial agents, e.g. triorganotin dithiocarbamates/26/, anti-tumour agents, notably of palladium and platinum/27-31/as well as tin dithiocarbamates/32, 33/, anti-parasitic agents, e.g. platinum, iridium and rhodium /34/, and prophylactic or therapeutic agents for metal toxicity, e.g. for cadmium /35/. Iron dithiocarbamates have been used for treating AIDS and neurodegenerative diseases/36/. As an extension of the aforementioned medical applications of dithiocarbamate ligands and their metal complexes, this contribution describes a study where dithiocarbamates have been combined with phosphinegold(1) entities with the view of exploring their anti-tumour potential.
Gold thiolates, including a phosphinegold(1) thiolate, auranofin, are used in the treatment of arthritis/37, 38/, usually after other therapies have been exhausted. The examination of the potential anti-tumour activity of gold complexes is a more recent phenomenon and has been demonstrated in a number of experimental models but, as yet, no gold compound has entered clinical trials. Auranofin and analogues were shown fo be . (6) 
Cytotoxicity Screening
The test and reference compounds were dissolved to a concentration of 250 000 ng/ml in full medium, by 20 fold dilution of a stock solution which contained mg compound/200 tl. The trial complexes (!)- (10) were taken into DMSO. However, it was noted that (2) , (4) and (5) Tables 2 4. The crystal structure of a representative complex has been undertaken.
The molecular structure of (p-MeOC6H4)aPAu(S2COiPr) (10) is shown in Fig. and selected geometric parameters are collected in the caption to this figure. The gold atom exists in the expected linear geometry defined by S and P donor atoms with the Au-S distance being significantly longer than the Au-P distance. The small deviation from the ideal linear angle at gold (S-Au-P is 176.75(5)) may be traced to the close approach of the non-coordinating $2 atom that is separated 3.2856 (16) (8) and (9) . The molecular geometry found for (10) is also as expected for their phosphinegold(1) dithiocarbamate analogues/58/and indeed, the crystal structures of (2) Ph3PAuS2COC4H9 (8) PhsPAu SCOCH2CH2OMe (9) (p-MeOPh)3PAuS2COiPr (10) (1)- (7), and xanthates, (8)- (10) (10) are given in Table 5 as well as those for a series of standard anti-cancer agents. From the data presented in Table 5 , several trends may be discerned.
The two dithiocarbamate iigands chosen for evaluation were featured in the Introduction owing to their known biological relevance. Amongst the diethyldithiocarbamates, the EtaP derivative (l) was the most active. The CyaP species (2) has comparable cytotoxicity to (l) and both are more potent than the (pMeOC6H4)aP derivative (3) . The complex containing the bidentate phosphine ligand dppf, where dppf is |, l'-bis(diphenylphosphine)ferrocene, that gives rise to a dinuclear gold species (4), has the poorest cytotoxicity, in particular considering it contains approximately twice the amount of gold as do the other species. The second dithiocarbamate series contains the pyrrolinedithiocarbamate ligand. Of the three complexes, (5)- (7), the PhaP species (6) is the most potent. The CyP complex (5) is less cytotoxic against all cell lines compared with the diethyldithiocarbamate analogue (2) but the reverse is true for the dppf derivatives in five cell lines, i.e. A498, MCF-7, EVSA-T, M I9 and W|DR. Such a non-systematic variation underscores the difficulty in generating a structure/activity relationship in these compounds. Amongst the xanthate, PhaPAu(SzCOR), complexes, R (CHz).CH3 (8) and CHzCHzOCH3 (9) had comparable potency to each other and both were more cytotoxic than (p,MeOC6H4)PAu(S2COiPr) (10) . As a class of complex, the xanthates are generally less cytotoxic than their dithiocarbamate analogues. The greatest potency exhibited by the xanthate complexes was against the ovarian cancer cell line |GROV but, it is noted that the range of IDa0 values against all cell lines is not great suggesting little, if any, specificity in their cytotoxicity profile.
The greatest potency exhibited by the dithiocarbamate complexes was also evident against the IGROV cell line and comparable activities were also found against the breast cancer cell lines MCF-7 and EVSA-T. The cytotoxicity results for the phosphinegold(1) I,l-dithiolates can be compared with those obtained for a selection of known anti-cancer agents.
C}'totoxicity Profilesfor a Series of Triorganophosphinegold (I) Dithiocarbamates Numbering scheme: Ca-O3, atoms of P-bound substituents, with Ca being adjacent to the phosphorus. J(P-C) values in parentheses. Table 4 Infrared data (cmt) for phosphinegold(l) l, l-dithiolates
(6) (7) (8) It is clear from the data presented in Table 5 
